References
- American Cancer SocietyBreast cancer overview Available from: http://www.cancer.org/Cancer/BreastCancer/OverviewGuide/Accessed June 1, 2010
- LigibelJABreast cancer metastasisHealthScout Available from: http://www.healthscout.com/ency/68/484/main.htmlAccessed June 1, 2010
- MayerMTreatments in common use for metastatic breast cancer Available from: http://www.advancedbc.org/content/treatmentscommon-use-metastatic-breast-cancer-gAccessed June 1, 2010
- BeusterienKBDaviesJLeachMPopulation preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility studyHealth Qual Life Outcomes201085020482804
- ArmstrongTAlmadronesLGilbertMRChemotherapy-induced peripheral neuropathyOncol Nurs Forum200532230531115759068
- SunCCBodurkaDCDonatoMLPatient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time?Gynecol Oncol200287111812812468352
- GreenPESrinivasanVConjoint analysis in marketing: new developments with implications for research and practiceJournal of Marketing1990544319
- RyanMFarrarSUsing conjoint analysis to elicit preferences for health careBMJ20003201530153310834905
- US Department of Health & Human ServicesHealth Information Privacy Available from: http://www.hhs.gov/ocr/privacyAccessed June 1, 2010
- BridgesJFHauberABMarshallDConjoint analysis applications in health – a checklist: a report of the ISPOR GoodResearch Practices for Conjoint Analysis Task ForceValue Health201114440341321669364
- GreenPEKriegerAMAgarwalMKAdaptive Conjoint Analysis: some cautions and caveatsJ Market199154319
- Sawtooth SoftwareACA/Web v6.0 Technical PaperSequim, WASawtooth Software, Inc2007 Available from http://sawtoothsoftware.comAccessed August 15, 2009
- JohnsonFRVan HoutvenGOzdemirSMultiple sclerosis patients’ benefit-risk preferences: serious adverse event risks versus treatment efficacyJ Neurol2009256455456219444531
- HauberABJohnsonFRGrotzingerKMOzdemirSPatients‘ benefit-risk preferences for chronic idiopathic thrombocytopenic purpura therapiesAnn Pharmacother201044347948820124463
- SasaneMTencerTFrenchAMaroTBeusterienKMPatient reported outcomes in chemotherapy-induced peripheral neuropathy: A reviewJ Support Oncol201086e15e21
- SunCCBodurkaDCWeaverCBRankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancerSupport Care Cancer20051321922715538640
- CalhounEAFishmanDALurainJRWelshmanEEBennettCLA comparison of ovarian cancer treatments: analysis of utility assessments of ovarian cancer patients, at-risk population, general population, and physiciansGynecol Oncol20049316416915047231
- BeusterienKMDziekanKSchraderSPatient preferences among third agent HIV medications: a US and German perspectiveAIDS Care200719898298817851994